Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 17/20 | 0.46 |
| ▸ | ADAM17 | P78536 | 15/20 | 0.46 |
| ▸ | MMP13 | P45452 | 14/20 | 0.46 |
| ▸ | MMP3 | P08254 | 3/20 | 0.43 |
| ▸ | MMP7 | P09237 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7150947 | 0.87 | ADAM17 (0.49) | MMP1ADAM17MMP13MMP3MMP9 | |
| SCHEMBL5761741 | 0.87 | ADAM17 (0.49) | MMP1ADAM17MMP13MMP3MMP9 | |
| SCHEMBL7150958 | 0.87 | ADAM17 (0.49) | MMP1ADAM17MMP13MMP3MMP9 | |
| SCHEMBL7150952 | 0.87 | ADAM17 (0.49) | MMP1ADAM17MMP13MMP3MMP9 | |
| SCHEMBL8432172 | 0.83 | MMP1 (0.61) | MMP1ADAM17MMP13MMP3MMP9 | |
| SCHEMBL8432174 | 0.83 | MMP1 (0.61) | MMP1ADAM17MMP13MMP3MMP9 | |
| SCHEMBL8435353 | 0.82 | MMP1 (0.66) | MMP1ADAM17MMP13MMP3 | |
| SCHEMBL8435351 | 0.82 | MMP1 (0.66) | MMP1ADAM17MMP13MMP3 | |
| SCHEMBL8570605 | 0.81 | ADAM17 (0.47) | MMP1ADAM17MMP13MMP3MMP7 | |
| SCHEMBL8521491 | 0.81 | ADAM17 (0.49) | MMP1ADAM17MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0960098-A1 | ARYLSULFONYL HYDROXAMIC ACID DERIVATIVES | PFIZER INC. (US) | 1999-12-01 | — | — | EP | disclosed |
| WO-1998034918-A1 | ARYLSULFONYL HYDROXAMIC ACID DERIVATIVES | PFIZER INC. (US) | 1998-08-13 | — | — | WO | disclosed |